opi

#Anthropic is preparing its #OPI historic IPO!
Files an application with the #SEC , targeting a November listing 🚀🤖

Anthropic filed its application to go public (Form S-1) with the SEC this Monday, intending to list in November. In the prospectus, the company reports revenue of $16.3 billion in the first half of 2026, alongside a net loss of $80.7 billion over the same period.

The number of shares to be issued and the price range have not yet been disclosed. Previous reports pointed to a fundraise of up to $100 billion and a valuation close to $2 trillion.
In the document, Anthropic says:

“We believe AI is one of the most consequential technologies in human history. If managed appropriately, it could rapidly accelerate scientific innovation, substantially increase rates of economic growth, facilitate access to cures for serious diseases, and solve problems that have resisted generations of human effort.”

The company, creator of #Claude , aims to become one of the largest IPOs in history as it faces high computing costs and a market closely watching both its explosive growth and its substantial losses.
$ANTHROPIC
$ICP

💤🚀 ¡HISTORIC OPERATION! Apnimed seeks to go public in the U.S. to launch its sleep apnea drug 🚀💤

The biotech company Apnimed Inc., strategically backed by Japanese giant Shionogi, officially filed its Initial Public Offering (IPO) in the United States under the symbol $APMD on Nasdaq, as reported by Bloomberg.

The company plans to use the funds raised to finance FDA regulatory approval and the commercial launch of Oxnimbi (AD109), its revolutionary daily oral drug.

This experimental treatment promises to be a historic medical alternative to the uncomfortable traditional air pressure machines (CPAP). 📊
$ADA
$BTC
$ETH

#Apnimed #OPI #IPO #Shionogi #PharmaNews